Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients

Recruiting N/A Interventional Study
Ulcerative Colitis (UC)
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 40
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of Veterinary and Animal Sciences, Lahore - Pakistan · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This randomized controlled trial aims to evaluate the effect of oral vitamin D3 supplementation on inflammatory biomarkers and disease activity in Pakistani patients with moderate ulcerative colitis. Sixty patients will be randomized to receive either standard treatment alone/Placebo or standard treatment plus vitamin D3 (50,000 IU fortnightly) for 12 weeks. Primary outcomes include changes in blo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * • All patients diagnosed previously by standard clinical i.e Truelove and Witts and endoscopic/ colonoscopic criteria * Patients with moderate ulcerative colitis will be included * Both male and female patients will be included in the study * No change in the type and d…
Contacts

Muhammad Barkaat Azam, PhD Scholar

923336654554

barkaatazam@gmail.com

CONTACT

Dr. Qaisar Raza, PhD

923002479044

qaisar.raza@uvas.edu.pk

CONTACT